Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Sales (2019 - 2025)

Historic Return on Sales for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to 0.78%.

  • Arcturus Therapeutics Holdings' Return on Sales fell 6200.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year decrease of 2900.0%. This contributed to the annual value of 0.53% for FY2024, which is 3500.0% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Return on Sales stood at 0.78% for Q3 2025, which was down 6200.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Sales registered a high of 0.74% during Q4 2022, and its lowest value of 27.11% during Q1 2021.
  • For the 5-year period, Arcturus Therapeutics Holdings' Return on Sales averaged around 5.49%, with its median value being 0.78% (2025).
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -235400bps in 2021, then surged by 260500bps in 2022.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Return on Sales stood at 6.5% in 2021, then soared by 111bps to 0.74% in 2022, then crashed by -151bps to 0.38% in 2023, then crashed by -248bps to 1.32% in 2024, then soared by 41bps to 0.78% in 2025.
  • Its last three reported values are 0.78% in Q3 2025, 0.32% for Q2 2025, and 0.48% during Q1 2025.